Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Axonics, Inc.

< Previous 1 2 Next >
Axonics to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics Receives Health Canada Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® to Participate in the Piper Sandler Healthcare Conference
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® Ranked No. 4 on the 2022 Deloitte Technology Fast 500™ List of the Fastest Growing Companies in North America
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® Reports Third Quarter 2022 Financial Results
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® to Report Third Quarter 2022 Financial Results on October 31
From Axonics, Inc.
Via Business Wire
Axonics® Announces First Patient Implants in Canada With New Recharge-Free Sacral Neuromodulation System
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® to Participate in September Investor Conferences
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® Expands Sacral Neuromodulation Intellectual Property Portfolio
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® Announces Closing of Public Stock Offering and Full Exercise of Underwriter’s Option to Purchase Additional Stock
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® Announces Pricing of Public Offering of Common Stock
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® Announces Proposed Public Offering of Common Stock
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® Reports Second Quarter 2022 Financial Results
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® to Report Second Quarter 2022 Financial Results on August 1
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® Files PMA Supplement with FDA for Fourth Generation Rechargeable Neurostimulator
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® Reports First Quarter 2022 Financial Results
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® to Participate in BofA Securities 2022 Healthcare Conference
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® Announces Comprehensive Launch of the Axonics F15™ Recharge-Free Sacral Neuromodulation System
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® to Report First Quarter 2022 Financial Results on May 5
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® Launches Direct to Consumer Television Advertising Campaign
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® Reports Fourth Quarter and Fiscal Year 2021 Financial Results
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 24
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® to Participate in SVB Leerink Virtual Healthcare Conference
From Axonics, Inc.
Via Business Wire
Tickers AXNX
New Study Finds More Than 60% of Adult Women in the U.S. Experience Urinary Incontinence
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® Reports Preliminary Fourth Quarter and Fiscal Year 2021 Revenue
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® CEO Raymond W. Cohen Receives Lifetime Entrepreneurial Achievement Award by the Southern California Biomedical Council
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® Ranked the Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500™
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® to Participate in Piper Sandler Virtual Healthcare Conference
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® Reports Third Quarter 2021 Financial Results
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics® Ranked the Fastest Growing Publicly Traded Company in Orange County
From Axonics, Inc.
Via Business Wire
Tickers AXNX
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.